Gaining access to financial services in the US is proving difficult for CBD companies, despite hemp being legalised at the federal level. The lack of a clear regulatory framework for CBD products has meant that many financial institutions place higher costs on CBD companies. This report addresses the reasons why the problem persists and what could be done to address it.
If you purchase a report that is updated in the next 60 days, we will send you the new report for free.
Reasons to buyThe problems around cannabis-related businesses obtaining banking and payment processing services are no secret, with such problems affecting not only cannabis but also CBD. This report offers a comprehensive summary of the problem as it stands along with some guidance and possible solutions.
Table of contents1 Executive summary
2 Introduction
3 Legal background
4 Some guidance provided
5 CBD more problematic than cannabis?
6 CBD product type matters
7 How big is the problem?
8 What can be done now
9 Long-term solutions
10 Regulatory guidance needed
MethodologyThe research is completely original and conducted by CBD-Intel’s multilingual legal analysis team using several sources, including online and offline resources and data, specialised legal software, interviews with key stakeholders and government officials, and via the collaboration with local lawyers and on-the-ground professionals.
Latest reportsGaining access to financial services in the US is proving difficult for CBD companies, despite hemp being legalised at the federal level. The lack of a clear regulatory framework for CBD products has meant that many financial institutions place higher costs on CBD companies. This report addresses the reasons why the problem persists and what could be done to address it.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.